DT56a. FLAXEED

DT56a is a unique preparation of flaxseed extract formulated to provide health benefits in the context of menopause. Flaxseed is known for its high content of lignans, which have been suggested to have beneficial effects on hormonal balance. DT56a has been specifically tailored to offer these benefits in a convenient and easy-to-use form.

Indications

DT56a flaxseed extract is indicated for the relief of menopausal symptoms, such as hot flashes, night sweats, and mood swings. It may also provide general support for bone health and cardiovascular function during menopause.

Dosage

Estrogen-Depleted female : 1 cap od/bid, with or without meals. One cap could be adequate for menopausal symptoms, but for osteoporosis and cardiovascular benefits, two capsules daily are needed. It needs to be taken life-long, and must be combined with other low-risk dietary constituents and behaviors for protective effects of phytoestrogens to be singnificantly manifest.

Contra-Indications

-Allergy to flaxseed or any components of DT56a. -Patients with a history of hormone-sensitive cancers, such as breast cancer, should consult a healthcare provider before taking DT56a. -Patients with gastrointestinal disorders such as Crohn’s disease, colitis, or other severe digestive issues should exercise caution.

Special Precautions

-DT56a flaxseed extract should be used with caution in patients with hormonal imbalances or who are on hormonal therapies. -It's important for individuals with pre-existing health conditions or those taking other medications to consult their healthcare provider before starting DT56a.

Side Effects

Common side effects include gastrointestinal discomfort such as bloating, gas, and nausea. Rarely, more serious allergic reactions can occur. If any severe side effects are experienced, seek medical attention immediately.

Drug Interactions

-Flaxseed extract may interact with medications that affect hormone levels, such as hormone replacement therapy (HRT) or oral contraceptives. -It may also interact with anticoagulant or antiplatelet drugs, potentially increasing the risk of bleeding.